Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: A meta-analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 7, 2005, Pages 3863-3870

  Baillargeon, Jean Patrice ^a   McClish, Donna K ^b   Essah, Paulina A ^b   Nestler, John E ^b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ACUTE HEART INFARCTION; AGE DISTRIBUTION; ARTICLE; BIOSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; HEART MUSCLE ISCHEMIA; HUMAN; LOW DRUG DOSE; MEDLINE; META ANALYSIS; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MYOCARDIAL INFARCTION; ODDS RATIO;

EID: 23044493043     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1958     Document Type: Article

References (39)

1. Centers for Disease Control and Prevention 1997 Vital and health statistics: fertility, family planning, and women's health: new data from the 1995 national survey of family growth, Centers for Disease Control and Prevention/National Center for Health Statistics Ser 23, No. 19, 49-51
2. United Nations 1999 World contraception use 1998. New York: United Nations
3. U.S. Census Bureau 2000 Projections of the total resident population by 5-year age groups, and sex with special age categories: middle series, 2001 to 2005, Population Projections Program, Population Division, No. NP-T3-B, 3. Washington, DC: U.S. Census Bureau
4. Burkman RT, Collins JA, Shulman LP, Williams JK 2001 Current perspectives on oral contraceptive use. Am J Obstet Gynecol 185:S4-S12
5. Mishell Jr DR 1992 Oral contraception: past, present, and future perspectives. Int J Fertil 37(Suppl 1):7-18
6. Kemmeren JM, Algra A, Grobbee DE 2001 Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ 323:131-134
7. Schwartz SM, Siscovick DS, Longstreth WT, Psaty BM, Beverly RK, Raghunathan TE, Lin DY, Koepsell TD 1997 Use of low-dose oral contraceptives and stroke in young women. Ann Intern Med 127(8 Pt 1):596-603
8. Rosenberg L, Palmer JR, Rao RS, Shapiro S 2001 Low-dose oral contraceptive use and the risk of myocardial infarction. Arch Intern Med 161:1065-1070
9. Petitti DB, Sidney S, Bernstein A, Wolf S, Quesenberry C, Ziel HK 1996 Stroke in users of low-dose oral contraceptives. N Engl J Med 335:8-15
10. Siritho S, Thrift AG, Mcneil JJ, You RX, Davis SM, Donnan GA 2003 Risk of ischemic stroke among users of the oral contraceptive pill: The Melbourne Risk Factor Study (MERFS) Group. Stroke 34:1575-1580
11. Petitti DB 2003 Clinical practice. Combination estrogen-progestin oral contraceptives. N Engl J Med 349:1443-1450
12. Curtis KM, Chrisman CE, Peterson HB 2002 Contraception for women in selected circumstances. Obstet Gynecol 99:1100-1112
13. World Health Organization 2000 Improving access to quality care in family planning: medical eligibility criteria for contraceptive use, 2nd ed. Geneva: World Health Organization
14. ACOG Practice Bulletin 2001 ACOG Practice Bulletin #18. The use of hormonal contraception in women with coexisting medical conditions. Int J Gynaecol Obstet 75:93-106
15. Reaven G 2001 Syndrome X. Curr Treat Options Cardiovasc Med 3:323-332
16. Nestler JE 1998 Polycystic ovary syndrome: a disorder for the generalist. Fertil Steril 70:811-812
17. Gillum LA, Mamidipudi SK, Johnston SC 2000 Ischemic stroke risk with oral contraceptives: a meta-analysis. JAMA 284:72-78
18. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE 1984 International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 108:150-158
19. Petitti DB 2000 Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine, 2nd ed, Monographs in epidemiology and biostatistics. New York: Oxford University Press
20. Kemmeren JM, Tanis BC, van den Bosch MA, Bollen EL, Helmerhorst FM, van der GY, Rosendaal FR, Algra A 2002 Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke 33:1202-1208
21. Lidegaard O 1998 Thrombotic diseases in young women and the influence of oral contraceptives. Am J Obstet Gynecol 179:S62-S67
22. Heinemann LAJ, Lewis MA, Spitzer WO, Thorogood M, Guggenmoos-Holzmann I, Bruppacher R 1998 Thromboembolic stroke in young women - a European case-control study on oral contraceptives. Contraception 57:29-37
23. Lewis MA, Heinemann LAJ, Spitzer WO, MacRae KD, Bruppacher R 1997 The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the transnational study on oral contraceptives and the health of young women. Contraception 56:129-140
24. Poulter NR, Chang CL, Farley TMM, Meirik O, Marmot MG, DebertRibeiro M, Medina E, Artigas J, Shen H, Zhong YH, Zhang DW, Zhao WJ, Rojas O, Vessey M, Heinemann L, Donnan S, Ho S, Bartfai G, Kisjanto J, Wilks R, Agwanda R, Ruiz R, KozuhNovak M, Dusitsin N, Virutamasen P, Phanthumcinda K, Koetsawang S, PiyaAnant M, Demirovic J, Belkic K, Mwandila WS, Mutale CM, Matenga J, Wilson A, Petitti D, Perlman J, Keleghan J, Lawley S, Smith S, Shipley M, Olsen J, Thorogood M 1996 Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet 348:498-505
25. Lidegaard O, Kreiner S 2002 Contraceptives and cerebral thrombosis: a five-year national case-control study. Contraception 65:197-205
26. Thorogood M, Mann J, Murphy M, Vessey M 1991 Is oral-contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case-control study. Br J Obstet Gynaecol 98:1245-1253
27. Poulter NR, Chang CL, Farley TMM, Kelaghan J, Meirlk O, Marmot MG, DebertRibeiro M, Medina E, Artigas J, He S, Zhong YH, Zhang DW, Zhao WJ, Rojas O, Heinemann L, Donnan S, Ho S, Bartfai G, Kisjanto J, Wilks R, Agwanda R, Ruiz R, KozuhNovak M, Dusitsin N, Virutamasen P, Phanthumchinda K, Koetsawang S, PiyaAnant M, Vessey M, Demirovic J, Belkic K, Mwandila WS, Mutale CM, Matenga J, Wilson A, Vessey MP, Petitti D, Perlman J, Kelaghan J, Holck S, Lawley S, Smith S, Shipley M, Olsen J, Thorogood M 1997 Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. Lancet 349:1202-1209
28. Sidney S, Siscovick DS, Petitti DB, Schwartz SM, Quesenberry CP, Psaty BM, Raghunathan TE, Kelaghan J, Koepsell TD 1998 Myocardial infarction and use of low-dose oral contraceptives: a pooled analysis of 2 US studies. Circulation 98:1058-1063
29. Dunn N, Thorogood M, Faragher B, de Caestecker L, MacDonald TM, McCollum C, Thomas S, Mann R 1999 Oral contraceptives and myocardial infarction: results of the MICA case-control study. BMJ 318:1579-1583
30. Tanis BC, van den Bosch MAAJ, Kemmeren JM, Cats VM, Helmerhorst FM, Algra A, van der Graaf Y, Rosendaal FR 2001 Oral contraceptives and the risk of myocardial infarction. N Engl J Med 345:1787-1793
31. Lidegaard O 1993 Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. BMJ 306:956-963
32. Heinemann LAJ 2000 Emerging evidence on oral contraceptives and arterial disease. Contraception 62:29S-36S
33. Spitzer WO, Faith JM, MacRae KD 2002 Myocardial infarction and third generation oral contraceptives: aggregation of recent studies. Hum Reprod 17:2307-2314
34. Khader YS, Rice J, John L, Abueita O 2003 Oral contraceptives use and the risk of myocardial infarction: a meta-analysis. Contraception 68:11-17
35. Chan WS, Ray J, Wai EK, Ginsburg S, Hannah ME, Corey PN, Ginsberg JS 2004 Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence. Arch Intern Med 164:741-747
36. Dunn NR, Arscott A, Thorogood M 2001 The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: results from the MICA case-control study. Contraception 63:65-69
37. Petitti DB, Sidney S, Quesenberry CP, Bernstein A 1997 Incidence of stroke and myocardial infarction in women of reproductive age. Stroke 28:280 -283
38. Baillargeon JP, Iuorno MJ, Nestler JE 2003 Insulin Sensitizers for polycystic ovary syndrome. In: Adashi EY, Scott JR, Gabbe SG, eds. Clinical obstetrics and gynecology. Philadelphia: Lippincott Williams & Wilkins; 325-340
39. Baillargeon JP, Iuorno MJ, Nestler JE 2002 Comparison of metformin and thiazolidinediones in the management of polycystic ovary syndrome. Curr Opin Endocrinol Diabetes 9:303-311